3 recruiting, 2 completed, 1 enrolling by invitation, 1 terminated. 8 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Recruiting 3, Completed 2, Enrolling by invitation 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Enrolling by invitation 1, Recruiting 1, Terminated 1 |
Follow Adenovirus: new trials by email Literature Review of Adenovirus trials Research Report on Adenovirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity Adenovirus Specific T- Lymphocytes, Cytomegalovirus Specific T-Lymphocytes, Epstein-Barr Virus Specific T-Lymphocytes - Adenovirus, Cytomegalovirus Infections | Phase 1 / Phase 2 | Recruiting | Jessie L. Alexander | 25 | 2025-04-30 | 2025-08-14 |
| R-MVST Cells for Treatment of Viral Infections in Children and Young Adults Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus, Cytomegalovirus Infections | Phase 1 | Recruiting | Monica Bhatia | 18 | 2025-04-20 | 2026-07-30 |
| Anti-viral T-cell Therapy by Gamma Capture Specific T- Lymphocytes - Adenovirus, Cytomegalovirus Infections | Phase 1 / Phase 2 | Enrolling by invitation | Paul Szabolcs | 25 | 2024-01-08 | 2026-06-29 |
| R-MVST Cells for Treatment of Viral Infections Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus Infections, Cytomegalovirus Infections | Phase 1 | Recruiting | Columbia University | 36 | 2022-05-03 | 2026-06-10 |
| Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV Adenovirus Specific T- Lymphocytes, Cytomegalovirus Specific T-Lymphocytes, EBV Specific T-Lymphocytes - Adenovirus, Cytomegalovirus Infections | Phase 1 / Phase 2 | Terminated | Jessie L. Alexander, MD | 8 | 2020-08-12 | 2026-05-27 |
| Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) CTL for CMV seropositive donors, CTL for CMV naïve donors - EBV, CMV | Phase 1 | Completed | Catherine Bollard | 27 | 2014-02-01 | 2025-07-03 |
| Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation Virus specific CTLs - CMV Infection, EBV | Phase 1 | Unknown | University of Sydney | 25 | 2013-01-01 | 2016-07-21 |
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV Cytotoxic T Lymphocytes - Epstein-Barr Virus Infections, Adenovirus | Phase 1 | Completed | Medical College of Wisconsin | 25 | 2012-02-01 | 2021-10-25 |
Adenoviridae Infections (8) · Cytomegalovirus Infections (7) · Epstein-Barr Virus Infections (6) · Immunologic Deficiency Syndromes (1)
DNA Virus Infections (8) · Infections (8) · Virus Diseases (8) · Herpesviridae Infections (7) · Tumor Virus Infections (6) · Immune System Diseases (1)
Cell Count (2)
Catherine Bollard (1) · Columbia University (1) · Jessie L. Alexander (1) · Jessie L. Alexander, MD (1) · Medical College of Wisconsin (1) · Monica Bhatia (1) · Paul Szabolcs (1) · University of Sydney (1)
United States (7) · Australia (1)
Jessie Alexander, MD (2) · Catherine Bollard, MD (1) · Julie-An Talano, MD (1) · Monica Bhatia, MD (1) · Paul Szabolcs, MD (1) · Pawel Muranski, MD (1)